Patent details

EP3927370 Title: METHODS FOR PRODUCING AUTOLOGOUS T CELLS USEFUL TO TREAT CANCERS AND COMPOSITIONS THEREOF

Basic Information

Publication number:
EP3927370
PCT Application Number:
US2020018711
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP207114612
PCT Publication Number:
WO2020172202
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
METHODS FOR PRODUCING AUTOLOGOUS T CELLS USEFUL TO TREAT CANCERS AND COMPOSITIONS THEREOF
French Title of Invention:
PROCÉDÉS DE PRODUCTION DE LYMPHOCYTES T AUTOLOGUES UTILISÉS POUR TRAITER LES CANCERS, ET COMPOSITIONS ASSOCIÉES
German Title of Invention:
VERFAHREN ZUR HERSTELLUNG AUTOLOGER T-ZELLEN ZUR BEHANDLUNG VON KREBS UND ZUSAMMENSETZUNGEN DAVON
SPC Number:

Dates

Filing date:
18/02/2020
Grant date:
24/04/2024
EP Publication Date:
29/12/2021
PCT Publication Date:
27/08/2020
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
24/04/2024
EP B1 Publication Date:
24/04/2024
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
18/02/2040
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
26/04/2024
 
 

Name:
Turnstone Biologics Corp.
Address:
9310 Athena Circle, Suite 300, La Jolla, CA 92037, United States (US)

History of Owners

From:
17/04/2024
To:
26/04/2024

Name:
Myst Therapeutics, LLC
Address:
920 Broadway, 16th Floor, New York, NY 10010, United States (US)

Agent

Name:
NLO
From:
29/04/2024
Address:
P.O. Box 29720, 2502 LS The Hague, Netherlands (NL)
To:

Inventor

1

Name:
LANGER, Timothy J.
Address:
United States (US)

2

Name:
CECCARELLI, Jacob
Address:
United States (US)

Priority

1

Priority Number:
201962807644 P
Priority Date:
19/02/2019
Priority Country:
United States (US)

2

Priority Number:
201962826974 P
Priority Date:
29/03/2019
Priority Country:
United States (US)

3

Priority Number:
201962941614 P
Priority Date:
27/11/2019
Priority Country:
United States (US)

4

Priority Number:
201962941610 P
Priority Date:
27/11/2019
Priority Country:
United States (US)

Classification

IPC classification:
A61K 39/00; A61P 35/00; A61P 37/04; C12N 5/0784; C12N 5/0783;

Publication

European Patent Bulletin

1

Issue number:
202417
Publication date:
24/04/2024
Description:
Grant (B1)

2

Issue number:
202423
Publication date:
05/06/2024
Description:
Document reprinted after correction (B8, B9)

3

Issue number:
202422
Publication date:
29/05/2024
Description:
Transfer of Rights

Annual Fees

Annual Fee Due Date:
02/03/2026
Annual Fee Number:
7
Annual Fee Amount:
82 Euro
Expected Payer:
Last Annual Fee Payment Date:
17/02/2025
Last Annual Fee Paid Number:
6
Last Annual Fee Paid Amount:
66 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
29/04/2024 Power Of Attorney 1
29/04/2024 Outgoing Correspondence 1